Enalapril (converting enzyme inhibitor) reduces the degree of left ventricular remodeling and reduces the incidence of ventricular arrhythmias in ischemic heart disease

New Trends in Arrhythmias

Volumn 9, Issue 3, 1993, Pages 615-632

  Altieri, P I ^a   Gonzalez, R ^a   De Mello, W C ^a   Escobales, N ^a  

^a UNIVERSITY OF PUERTO RICO   (Puerto Rico)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ATRIAL NATRIURETIC FACTOR; ENALAPRIL; NORADRENALIN; PLACEBO;

ADULT; AGED; CLINICAL ARTICLE; CLINICAL TRIAL; COMPLICATION; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG THERAPY; FEMALE; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE REMODELING; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0027740623     PISSN: 03935302     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (0)